BIVI
Price
$1.01
Change
-$0.02 (-1.94%)
Updated
Jun 27, 12:41 PM (EDT)
Capitalization
19.13M
HMTXF
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Jun 25 closing price
Capitalization
13.76M
Interact to see
Advertisement

BIVI vs HMTXF

Header iconBIVI vs HMTXF Comparison
Open Charts BIVI vs HMTXFBanner chart's image
BioVie
Price$1.01
Change-$0.02 (-1.94%)
Volume$300
Capitalization19.13M
Hemostemix
Price$0.10
Change-$0.00 (-0.00%)
Volume$2K
Capitalization13.76M
BIVI vs HMTXF Comparison Chart in %
Loading...
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIVI vs. HMTXF commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIVI is a Hold and HMTXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (BIVI: $1.03 vs. HMTXF: $0.10)
Brand notoriety: BIVI and HMTXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIVI: 35% vs. HMTXF: 6%
Market capitalization -- BIVI: $19.13M vs. HMTXF: $13.76M
BIVI [@Biotechnology] is valued at $19.13M. HMTXF’s [@Biotechnology] market capitalization is $13.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIVI’s FA Score shows that 1 FA rating(s) are green whileHMTXF’s FA Score has 1 green FA rating(s).

  • BIVI’s FA Score: 1 green, 4 red.
  • HMTXF’s FA Score: 1 green, 4 red.
According to our system of comparison, HMTXF is a better buy in the long-term than BIVI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIVI’s TA Score shows that 3 TA indicator(s) are bullish.

  • BIVI’s TA Score: 3 bullish, 4 bearish.

Price Growth

BIVI (@Biotechnology) experienced а -5.50% price change this week, while HMTXF (@Biotechnology) price change was +5.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.93%. For the same industry, the average monthly price growth was +39.30%, and the average quarterly price growth was +17.52%.

Reported Earning Dates

BIVI is expected to report earnings on Nov 27, 2024.

Industries' Descriptions

@Biotechnology (+9.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIVI($19.1M) has a higher market cap than HMTXF($13.8M). HMTXF YTD gains are higher at: 30.464 vs. BIVI (-48.500). HMTXF has higher annual earnings (EBITDA): -2.79M vs. BIVI (-18M). BIVI has more cash in the bank: 23.2M vs. HMTXF (965K). BIVI has less debt than HMTXF: BIVI (366K) vs HMTXF (4.69M). BIVI (0) and HMTXF (0) have equivalent revenues.
BIVIHMTXFBIVI / HMTXF
Capitalization19.1M13.8M138%
EBITDA-18M-2.79M645%
Gain YTD-48.50030.464-159%
P/E RatioN/AN/A-
Revenue00-
Total Cash23.2M965K2,404%
Total Debt366K4.69M8%
FUNDAMENTALS RATINGS
BIVI vs HMTXF: Fundamental Ratings
BIVI
HMTXF
OUTLOOK RATING
1..100
7053
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
8735
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HMTXF's Valuation (4) in the null industry is in the same range as BIVI (17). This means that HMTXF’s stock grew similarly to BIVI’s over the last 12 months.

HMTXF's Profit vs Risk Rating (100) in the null industry is in the same range as BIVI (100). This means that HMTXF’s stock grew similarly to BIVI’s over the last 12 months.

BIVI's SMR Rating (98) in the null industry is in the same range as HMTXF (100). This means that BIVI’s stock grew similarly to HMTXF’s over the last 12 months.

HMTXF's Price Growth Rating (35) in the null industry is somewhat better than the same rating for BIVI (87). This means that HMTXF’s stock grew somewhat faster than BIVI’s over the last 12 months.

HMTXF's P/E Growth Rating (100) in the null industry is in the same range as BIVI (100). This means that HMTXF’s stock grew similarly to BIVI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIVI
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BIVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLDN62.173.03
+5.12%
Willdan Group
CNVS4.180.19
+4.76%
Cineverse Corp
MT31.650.64
+2.06%
ArcelorMittal
RGCO22.320.38
+1.73%
RGC Resources
ALRM56.40-0.60
-1.05%
Alarm.com Holdings

BIVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIVI has been loosely correlated with HURA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BIVI jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIVI
1D Price
Change %
BIVI100%
N/A
HURA - BIVI
47%
Loosely correlated
+2.69%
HOFBF - BIVI
44%
Loosely correlated
N/A
SCNI - BIVI
34%
Loosely correlated
-1.98%
BIORQ - BIVI
34%
Loosely correlated
+4.59%
ATAI - BIVI
27%
Poorly correlated
+2.27%
More

HMTXF and

Correlation & Price change

A.I.dvisor tells us that HMTXF and DMAC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HMTXF and DMAC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HMTXF
1D Price
Change %
HMTXF100%
N/A
DMAC - HMTXF
22%
Poorly correlated
-3.54%
BIVI - HMTXF
21%
Poorly correlated
N/A
AGEN - HMTXF
21%
Poorly correlated
-0.41%
DVHGF - HMTXF
21%
Poorly correlated
N/A
FDMT - HMTXF
12%
Poorly correlated
-0.25%
More